(29 April 2025, Hong Kong) HKSH Medical Group (HKSH) is pleased to announce the generous donation of the revolutionary Histotripsy 2.0 system by the Li Ka Shing Foundation (LKSF). This innovative, non-invasive liver cancer treatment, utilising high-intensity focused ultrasound to precisely target liver tumours, enhances HKSH’s established capabilities in liver cancer care, offering patients even more targeted, comprehensive and personalised treatment options. Following meticulous preparations, specialised training, and rigorous clinical governance protocols, the dedicated team of HKSH Cancer Centre has launched the “Non-Invasive Liver Cancer Histotripsy Treatment Programme” with pre-treatment assessments began in mid-April, and the first Histotripsy procedure scheduled for early May, bringing more advanced treatment and disease management opportunities for liver cancer patients.

Please click here [1] for more information.